BAFN vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a critically weak financial health with a Piotroski F-Score of just 2/9, indicating severe operational and balance sheet deterioration. Despite a low Price/Book of 0.37 and a 4.78% dividend yield, the company is unprofitable with a -18.15% profit margin and negative ROE of -11.14%, undermining valuation appeal. The technical trend is deeply bearish at 0/100, consistent with a 1-year price decline of -55.8% and no analyst coverage, signaling market disregard. Absence of Altman Z-Score and key financials like debt/equity and cash flow further heightens uncertainty, suggesting potential distress risk.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BAFN vs JPM: Head-to-Head Comparison
This page compares BayFirst Financial Corp. (BAFN) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.